First Trust Advisors LP Makes New Investment in Ocular Therapeutix, Inc. (NASDAQ:OCUL)
First Trust Advisors LP bought a new position in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) during the 4th quarter, Holdings Channel reports. The fund bought 212,944 shares of the biopharmaceutical company’s stock, valued at approximately $1,819,000. A number of other institutional investors and hedge funds have also made changes to their positions […]
First Trust Advisors LP bought a new position in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) during the 4th quarter, Holdings Channel reports. The fund bought 212,944 shares of the biopharmaceutical company’s stock, valued at approximately $1,819,000. A number of other institutional investors and hedge funds have also made changes to their positions […]
